ALR Technologies is seeking a U.S. FDA 510(k) approval for the Insulin Dose Adjustment Consultation (IDAC) feature of its Health-e-Connect chronic care platform. The company officials say the new tool would draw data from a blood glucose meter, add information on one’s height and weight, and insulin dose history, and feed it through an algorithm to provide doctors with real-time guidelines on how much insulin to prescribe at a given moment.
“The proper dosing of insulin is one of the most important challenges in the clinical practice of diabetes,” Bill Smith, president of Richmond, Va.-based ALR Technologies, said in a recent press release. “According to the Institute for Safe Medication Practices (ISMP), insulin accounts for more than 10 percent of all drug dosing mistakes. Health-e-Connect with IDAC is an easy way for a prescribing clinician to optimize a patient’s insulin dose without an office visit while avoiding common errors.”
The capability would also expand the clinician’s online toolbox for diabetes care management, which now falls under the Centers for Medicare and Medicaid Services’ list of reimbursable care coordination activities.
The Insulin Dose Adjustment Consultation feature would also expand the clinician’s online toolbox for diabetes care management.ALR’s Health-e-Connect platform allows patients to upload diabetic’s blood glucose meter results onto a secure website, where the data is viewed by the company’s diabetes care facilitators and the patient’s selected caregivers. Alerts and other messages can then be sent back to the patient, while clinicians can be alerted for an immediate intervention if needed.
“Research shows that intensive management can avoid significant micro-vascular complications and comorbidities resulting from poor blood glucose control,” Sidney Chan, ALRT’s chief executive officer and chairman, said in the release. “Besides these serious health consequences for patients, the poor outcomes produced by improper insulin dosing lead to significant, unnecessary healthcare costs.”
[Via: mHealthNews]